EMYRIA LIMITED - Announcements

Market Cap $18.69M Add to my watchlist

Healthcare

Emyria Limited is an Australia-based clinical services and drug development company. The... Emyria Limited is an Australia-based clinical services and drug development company. The Company is focused on developing patient outcomes in neuroscience and mental health through its clinical service delivery, proprietary real-world data (RWD), and drug discovery & development. It delivers evidence-based and emerging therapies for mental health and other unmet needs through its Emerald Clinics and the Pax Centre. Emerald Clinics specializes in providing treatments for patients with complex and chronic conditions. The Pax Centre specializes in treating individuals grappling with the psychological impacts of traumatic experiences. Through its advanced data platform operated by Palantir, the Company collects robust and ethically sourced real-world data to improve its care models and support its distinct therapy and drug development initiatives. The Company is also developing several proprietary ultra-pure cannabinoid dose forms and advancing them towards registration, such as EMD-RX5.More

NATURAL MEDICINE LEADERS

ASX-listed wellness consumer discretionary player Calmer Co (ASX:CCO) has revealed its e-commerce sales hit more than $10K per day in March.

Announcements

Filter Results

All Price Sensitive Only

EMD	March 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	26/04/24	516.19KB	Share
EMD	Proposed issue of securities - EMD		23/04/24	27.99KB	Share
EMD	Emyria Receives Bids of $2.3M to Expand Clinical Services	PRICE SENSITIVE	23/04/24	674.43KB	Share
EMD	Trading Halt	PRICE SENSITIVE	19/04/24	779.23KB	Share
EMD	Emyria Opens Empax Centre to Advance Mental Health Care	PRICE SENSITIVE	10/04/24	1.92MB	Share
EMD	Emyria Expands Specialist AP Team - First Female for MDMA-AT	PRICE SENSITIVE	05/04/24	449.97KB	Share
EMD	Emyria, Reach Wellness Enter MDMA-AT Research Agreement	PRICE SENSITIVE	03/04/24	688.66KB	Share
EMD	Notification of cessation of securities - EMD		19/03/24	13.77KB	Share
EMD	Response to ASX Aware Query	PRICE SENSITIVE	12/03/24	1014.06KB	Share
EMD	Response to ASX Price Query	PRICE SENSITIVE	08/03/24	962.69KB	Share
EMD	Emyria Half Year Results FY2024		29/02/24	337.57KB	Share
EMD	Appendix 4D and Half Year End Financial Report	PRICE SENSITIVE	28/02/24	979.17KB	Share
EMD	Notification of cessation of securities - EMD		23/02/24	13.89KB	Share
EMD	Webinar Presentation		02/02/24	3.75MB	Share
EMD	December 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/24	1.26MB	Share
EMD	Notification of cessation of securities - EMD		30/01/24	23.28KB	Share
EMD	Emyria Receives $2.5M R&D Tax Incentive Refund	PRICE SENSITIVE	15/01/24	326.75KB	Share
EMD	Company Overview and Strategic Update		10/01/24	6.18MB	Share
EMD	Emyria Specialist Granted Authorised Prescriber Status	PRICE SENSITIVE	10/01/24	786.2KB	Share
EMD	Change of Director's Interest Notice - M. Winlo		02/01/24	224.73KB	Share
EMD	Change in Substantial Holding		27/11/23	327.97KB	Share
EMD	Notification of cessation of securities - EMD		27/11/23	22.69KB	Share
EMD	Initial Director's Interest Notice - G. Hutchinson		22/11/23	185.03KB	Share
EMD	Final Director's Interest Notice - S. Washer		22/11/23	165.26KB	Share
EMD	Eminent Healthcare Leader New Independent Non-Exec Chair		21/11/23	894.49KB	Share
EMD	Application for quotation of securities - EMD		21/11/23	29.03KB	Share
EMD	Results of Annual General Meeting		16/11/23	91.89KB	Share
EMD	Final Director's Interest Notice - A. Vickery		13/11/23	157.32KB	Share
EMD	Board Changes and Executive Restructuring	PRICE SENSITIVE	13/11/23	714.67KB	Share
EMD	Section 708A(5)(e) Notice		10/11/23	88.02KB	Share
EMD	Application for quotation of securities - EMD		10/11/23	26.82KB	Share
EMD	Notification regarding unquoted securities - EMD		10/11/23	30.81KB	Share
EMD	Change of Director's Interest Notice - A. Vickery		10/11/23	286.07KB	Share
EMD	Results of General Meeting		31/10/23	101.9KB	Share
EMD	Emyria Secures Ethics Endorsement for MDMA AP Application	PRICE SENSITIVE	30/10/23	453.79KB	Share
EMD	ASA Virtual Investor Summit Presentation October 2023		27/10/23	6.31MB	Share
EMD	September 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	26/10/23	2.01MB	Share
EMD	Change in substantial holding		24/10/23	114.12KB	Share
EMD	Health Canada Approval Received for MDMA Import	PRICE SENSITIVE	19/10/23	708.64KB	Share
EMD	Letter to Shareholders - Notice of Annual General Meeting		13/10/23	266.63KB	Share
EMD	Notice of Annual General Meeting/Proxy Form		13/10/23	519.44KB	Share
EMD	Section 708A(5)(e) Notice		10/10/23	87.79KB	Share
EMD	Notification of cessation of securities - EMD		10/10/23	23.41KB	Share
EMD	Application for quotation of securities - EMD		10/10/23	26.79KB	Share
EMD	Change of Director's Interest Notice x 3		10/10/23	364.15KB	Share
EMD	Change in substantial holding		10/10/23	137.8KB	Share
EMD	Emyria's Clinic Achieves Key MDMA-AT Dosing Milestone	PRICE SENSITIVE	09/10/23	764.02KB	Share
EMD	Application for quotation of securities - EMD		05/10/23	26.74KB	Share
EMD	Notification regarding unquoted securities - EMD		05/10/23	25.98KB	Share
EMD	Completion of Entitlement Offer	PRICE SENSITIVE	05/10/23	784.09KB	Share
EMD	Letter to Shareholders - Notice of General Meeting		28/09/23	265.44KB	Share
EMD	Notice of General Meeting/Proxy Form		28/09/23	474.82KB	Share
EMD	2023 Annual Report		27/09/23	4.81MB	Share
EMD	Appendix 4G and Corporate Governance Statement		27/09/23	489.9KB	Share
EMD	Emyria Secures Local MDMA to Start PTSD Trial Dosing	PRICE SENSITIVE	21/09/23	770.68KB	Share
EMD	Prospectus & Application Forms Available to Eligible Holders		18/09/23	169.82KB	Share
EMD	Notice to Ineligible Shareholders of Entitlement Offer		13/09/23	252.68KB	Share
EMD	Section 708A(5)(e) Notice		13/09/23	88.76KB	Share
EMD	Emyria Completes Acquisition of the Pax Centre	PRICE SENSITIVE	13/09/23	763.21KB	Share
EMD	Application for quotation of securities - EMD		13/09/23	29.24KB	Share
EMD	Application for quotation of securities - EMD		13/09/23	26.79KB	Share
EMD	Notice to Optionholders - Non-Renounceable Entitlement Offer		06/09/23	231.06KB	Share
EMD	Becoming a substantial holder		06/09/23	212.88KB	Share
EMD	Strategic Update & Entitlement Offer Presentation	PRICE SENSITIVE	06/09/23	9.15MB	Share
EMD	Prospectus	PRICE SENSITIVE	06/09/23	635.86KB	Share
EMD	Notification of cessation of securities - EMD		05/09/23	22.87KB	Share
EMD	Proposed issue of securities - EMD		04/09/23	57.25KB	Share
EMD	Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer	PRICE SENSITIVE	04/09/23	854.7KB	Share
EMD	Trading Halt	PRICE SENSITIVE	31/08/23	723.52KB	Share
EMD	Appendix 4E Preliminary Financial Report	PRICE SENSITIVE	30/08/23	253.14KB	Share
EMD	2023 Annual General Meeting - Key Dates		30/08/23	220.93KB	Share
EMD	Final Director's Interest Notice - M. Callahan		23/08/23	157.11KB	Share
EMD	Initial Director's Interest Notice - M. Kaushal		23/08/23	184.96KB	Share
EMD	Notification of cessation of securities - EMD		23/08/23	23.18KB	Share
EMD	Notification regarding unquoted securities - EMD		23/08/23	29.11KB	Share
EMD	Emyria Announces Strategic Board Transition		21/08/23	795.63KB	Share
EMD	Change of Director's Interest Notice - A. Vickery		11/08/23	228.3KB	Share
EMD	Change of Director's Interest Notice - S. Washer		10/08/23	232.72KB	Share
EMD	Change of Director's Interest Notice - M. Winlo		09/08/23	225.45KB	Share
EMD	Emyria Launches Ketamine-Assisted Therapy Program	PRICE SENSITIVE	08/08/23	1.22MB	Share
EMD	June 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/07/23	773.99KB	Share
EMD	Emyria Recruits First Patient MDMA-Assisted Therapy Trial	PRICE SENSITIVE	10/07/23	925.91KB	Share
EMD	Presentation - Pax Acquisition and Company Update	PRICE SENSITIVE	06/07/23	7.92MB	Share
EMD	Proposed issue of securities - EMD		03/07/23	25.5KB	Share
EMD	Pax Centre Acquisition to Advance Psychedelic Therapies	PRICE SENSITIVE	03/07/23	1.1MB	Share
EMD	Trading Halt	PRICE SENSITIVE	29/06/23	374.84KB	Share
EMD	Emyria Receives Ethics Approval for MDMA-assisted Therapy	PRICE SENSITIVE	08/06/23	717.18KB	Share
EMD	Section 708A(5)(e) Notice		10/05/23	303.92KB	Share
EMD	Application for quotation of securities - EMD		10/05/23	26.56KB	Share
EMD	Notification regarding unquoted securities - EMD		10/05/23	30.02KB	Share
EMD	Proposed issue of securities - EMD		01/05/23	29.17KB	Share
EMD	Emyria Completes $2.5m Placement	PRICE SENSITIVE	01/05/23	630.65KB	Share
EMD	March 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/04/23	815.17KB	Share
EMD	Trading Halt	PRICE SENSITIVE	27/04/23	700.42KB	Share
EMD	Emyria Unveils Highest Potency CBD Capsule for FDA Pathway	PRICE SENSITIVE	24/04/23	631.36KB	Share
EMD	Emyria to Develop Psilocybin Therapy Care Model	PRICE SENSITIVE	18/04/23	1.16MB	Share
EMD	Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5	PRICE SENSITIVE	04/04/23	1.16MB	Share
EMD	Strong Recruitment for EMD-RX5 Phase 3 Trial	PRICE SENSITIVE	23/03/23	1.19MB	Share
EMD	Emyria Grows MDMA Asset for Neuro & Mental Health Therapy	PRICE SENSITIVE	20/03/23	638.15KB	Share
EMD	Broker Briefing Presentation		16/03/23	6MB	Share

EMD March 2024 Quarterly Activities Report and Appendix 4C
26/04/24	PRICE SENSITIVE	516.19KB	Share
EMD Proposed issue of securities - EMD
23/04/24		27.99KB	Share
EMD Emyria Receives Bids of $2.3M to Expand Clinical Services
23/04/24	PRICE SENSITIVE	674.43KB	Share
EMD Trading Halt
19/04/24	PRICE SENSITIVE	779.23KB	Share
EMD Emyria Opens Empax Centre to Advance Mental Health Care
10/04/24	PRICE SENSITIVE	1.92MB	Share
EMD Emyria Expands Specialist AP Team - First Female for MDMA-AT
05/04/24	PRICE SENSITIVE	449.97KB	Share
EMD Emyria, Reach Wellness Enter MDMA-AT Research Agreement
03/04/24	PRICE SENSITIVE	688.66KB	Share
EMD Notification of cessation of securities - EMD
19/03/24		13.77KB	Share
EMD Response to ASX Aware Query
12/03/24	PRICE SENSITIVE	1014.06KB	Share
EMD Response to ASX Price Query
08/03/24	PRICE SENSITIVE	962.69KB	Share
EMD Emyria Half Year Results FY2024
29/02/24		337.57KB	Share
EMD Appendix 4D and Half Year End Financial Report
28/02/24	PRICE SENSITIVE	979.17KB	Share
EMD Notification of cessation of securities - EMD
23/02/24		13.89KB	Share
EMD Webinar Presentation
02/02/24		3.75MB	Share
EMD December 2023 Quarterly Activities Report and Appendix 4C
31/01/24	PRICE SENSITIVE	1.26MB	Share
EMD Notification of cessation of securities - EMD
30/01/24		23.28KB	Share
EMD Emyria Receives $2.5M R&D Tax Incentive Refund
15/01/24	PRICE SENSITIVE	326.75KB	Share
EMD Company Overview and Strategic Update
10/01/24		6.18MB	Share
EMD Emyria Specialist Granted Authorised Prescriber Status
10/01/24	PRICE SENSITIVE	786.2KB	Share
EMD Change of Director's Interest Notice - M. Winlo
02/01/24		224.73KB	Share
EMD Change in Substantial Holding
27/11/23		327.97KB	Share
EMD Notification of cessation of securities - EMD
27/11/23		22.69KB	Share
EMD Initial Director's Interest Notice - G. Hutchinson
22/11/23		185.03KB	Share
EMD Final Director's Interest Notice - S. Washer
22/11/23		165.26KB	Share
EMD Eminent Healthcare Leader New Independent Non-Exec Chair
21/11/23		894.49KB	Share
EMD Application for quotation of securities - EMD
21/11/23		29.03KB	Share
EMD Results of Annual General Meeting
16/11/23		91.89KB	Share
EMD Final Director's Interest Notice - A. Vickery
13/11/23		157.32KB	Share
EMD Board Changes and Executive Restructuring
13/11/23	PRICE SENSITIVE	714.67KB	Share
EMD Section 708A(5)(e) Notice
10/11/23		88.02KB	Share
EMD Application for quotation of securities - EMD
10/11/23		26.82KB	Share
EMD Notification regarding unquoted securities - EMD
10/11/23		30.81KB	Share
EMD Change of Director's Interest Notice - A. Vickery
10/11/23		286.07KB	Share
EMD Results of General Meeting
31/10/23		101.9KB	Share
EMD Emyria Secures Ethics Endorsement for MDMA AP Application
30/10/23	PRICE SENSITIVE	453.79KB	Share
EMD ASA Virtual Investor Summit Presentation October 2023
27/10/23		6.31MB	Share
EMD September 2023 Quarterly Activities Report and Appendix 4C
26/10/23	PRICE SENSITIVE	2.01MB	Share
EMD Change in substantial holding
24/10/23		114.12KB	Share
EMD Health Canada Approval Received for MDMA Import
19/10/23	PRICE SENSITIVE	708.64KB	Share
EMD Letter to Shareholders - Notice of Annual General Meeting
13/10/23		266.63KB	Share
EMD Notice of Annual General Meeting/Proxy Form
13/10/23		519.44KB	Share
EMD Section 708A(5)(e) Notice
10/10/23		87.79KB	Share
EMD Notification of cessation of securities - EMD
10/10/23		23.41KB	Share
EMD Application for quotation of securities - EMD
10/10/23		26.79KB	Share
EMD Change of Director's Interest Notice x 3
10/10/23		364.15KB	Share
EMD Change in substantial holding
10/10/23		137.8KB	Share
EMD Emyria's Clinic Achieves Key MDMA-AT Dosing Milestone
09/10/23	PRICE SENSITIVE	764.02KB	Share
EMD Application for quotation of securities - EMD
05/10/23		26.74KB	Share
EMD Notification regarding unquoted securities - EMD
05/10/23		25.98KB	Share
EMD Completion of Entitlement Offer
05/10/23	PRICE SENSITIVE	784.09KB	Share
EMD Letter to Shareholders - Notice of General Meeting
28/09/23		265.44KB	Share
EMD Notice of General Meeting/Proxy Form
28/09/23		474.82KB	Share
EMD 2023 Annual Report
27/09/23		4.81MB	Share
EMD Appendix 4G and Corporate Governance Statement
27/09/23		489.9KB	Share
EMD Emyria Secures Local MDMA to Start PTSD Trial Dosing
21/09/23	PRICE SENSITIVE	770.68KB	Share
EMD Prospectus & Application Forms Available to Eligible Holders
18/09/23		169.82KB	Share
EMD Notice to Ineligible Shareholders of Entitlement Offer
13/09/23		252.68KB	Share
EMD Section 708A(5)(e) Notice
13/09/23		88.76KB	Share
EMD Emyria Completes Acquisition of the Pax Centre
13/09/23	PRICE SENSITIVE	763.21KB	Share
EMD Application for quotation of securities - EMD
13/09/23		29.24KB	Share
EMD Application for quotation of securities - EMD
13/09/23		26.79KB	Share
EMD Notice to Optionholders - Non-Renounceable Entitlement Offer
06/09/23		231.06KB	Share
EMD Becoming a substantial holder
06/09/23		212.88KB	Share
EMD Strategic Update & Entitlement Offer Presentation
06/09/23	PRICE SENSITIVE	9.15MB	Share
EMD Prospectus
06/09/23	PRICE SENSITIVE	635.86KB	Share
EMD Notification of cessation of securities - EMD
05/09/23		22.87KB	Share
EMD Proposed issue of securities - EMD
04/09/23		57.25KB	Share
EMD Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer
04/09/23	PRICE SENSITIVE	854.7KB	Share
EMD Trading Halt
31/08/23	PRICE SENSITIVE	723.52KB	Share
EMD Appendix 4E Preliminary Financial Report
30/08/23	PRICE SENSITIVE	253.14KB	Share
EMD 2023 Annual General Meeting - Key Dates
30/08/23		220.93KB	Share
EMD Final Director's Interest Notice - M. Callahan
23/08/23		157.11KB	Share
EMD Initial Director's Interest Notice - M. Kaushal
23/08/23		184.96KB	Share
EMD Notification of cessation of securities - EMD
23/08/23		23.18KB	Share
EMD Notification regarding unquoted securities - EMD
23/08/23		29.11KB	Share
EMD Emyria Announces Strategic Board Transition
21/08/23		795.63KB	Share
EMD Change of Director's Interest Notice - A. Vickery
11/08/23		228.3KB	Share
EMD Change of Director's Interest Notice - S. Washer
10/08/23		232.72KB	Share
EMD Change of Director's Interest Notice - M. Winlo
09/08/23		225.45KB	Share
EMD Emyria Launches Ketamine-Assisted Therapy Program
08/08/23	PRICE SENSITIVE	1.22MB	Share
EMD June 2023 Quarterly Activities Report and Appendix 4C
31/07/23	PRICE SENSITIVE	773.99KB	Share
EMD Emyria Recruits First Patient MDMA-Assisted Therapy Trial
10/07/23	PRICE SENSITIVE	925.91KB	Share
EMD Presentation - Pax Acquisition and Company Update
06/07/23	PRICE SENSITIVE	7.92MB	Share
EMD Proposed issue of securities - EMD
03/07/23		25.5KB	Share
EMD Pax Centre Acquisition to Advance Psychedelic Therapies
03/07/23	PRICE SENSITIVE	1.1MB	Share
EMD Trading Halt
29/06/23	PRICE SENSITIVE	374.84KB	Share
EMD Emyria Receives Ethics Approval for MDMA-assisted Therapy
08/06/23	PRICE SENSITIVE	717.18KB	Share
EMD Section 708A(5)(e) Notice
10/05/23		303.92KB	Share
EMD Application for quotation of securities - EMD
10/05/23		26.56KB	Share
EMD Notification regarding unquoted securities - EMD
10/05/23		30.02KB	Share
EMD Proposed issue of securities - EMD
01/05/23		29.17KB	Share
EMD Emyria Completes $2.5m Placement
01/05/23	PRICE SENSITIVE	630.65KB	Share
EMD March 2023 Quarterly Activities Report and Appendix 4C
28/04/23	PRICE SENSITIVE	815.17KB	Share
EMD Trading Halt
27/04/23	PRICE SENSITIVE	700.42KB	Share
EMD Emyria Unveils Highest Potency CBD Capsule for FDA Pathway
24/04/23	PRICE SENSITIVE	631.36KB	Share
EMD Emyria to Develop Psilocybin Therapy Care Model
18/04/23	PRICE SENSITIVE	1.16MB	Share
EMD Emyria, Aspen Sign Binding Commercial Term Sheet for EMD-RX5
04/04/23	PRICE SENSITIVE	1.16MB	Share
EMD Strong Recruitment for EMD-RX5 Phase 3 Trial
23/03/23	PRICE SENSITIVE	1.19MB	Share
EMD Emyria Grows MDMA Asset for Neuro & Mental Health Therapy
20/03/23	PRICE SENSITIVE	638.15KB	Share
EMD Broker Briefing Presentation
16/03/23		6MB	Share

REFRESH

1 2 3

(20min delay)
Last 5.1¢		Change 0.000(0.00%)		Mkt cap ! $18.69M

Open	High	Low	Value	Volume
5.0¢	5.1¢	4.9¢	$17.76K	359.9K

Buyers (Bids)

No.	Vol.	Price($)
1	204081	4.9¢

Sellers (Offers)

Price($)	Vol.	No.
5.1¢	42827	2

View Market Depth

No.	Vol.	Price($)
1	204081	0.049
2	29191	0.048
1	11000	0.047
1	200000	0.046
2	111155	0.045

Price($)	Vol.	No.
0.051	42827	2
0.052	65193	1
0.053	10000	1
0.062	51000	1
0.064	125693	2

Last trade - 15.59pm 06/05/2024 (20 minute delay)


Last 4.9¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
5.0¢	5.0¢	4.9¢	39731
Last updated 12.36pm 06/05/2024 ?

EMD (ASX) Chart

EMYRIA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories